...Thank you, Catherine, and thanks to those of you attending today's earnings call. Dr. Shai Gozani, President and CEO of NeuroMetrix, is participating in this call. By way of background, NeuroMetrix is a Boston-based medical device company with extensive proprietary intellectual property. We are innovation driven and focused on the development and global commercialization of noninvasive medical devices for the diagnosis and treatment of pain and neurological disorders. Our business model is based on recurring revenue from our installed customer base. During the third quarter, our revenue was $2.1 million. This was up slightly or 1% from Q3 of last year. Aftermarket revenue as a percentage of that total was 82% versus 80% in Q3, 2020. DPNCheck, our diagnostic for peripheral neuropathy, contributed the majority of sales and grew 7% year-on-year. Its sales are primarily concentrated in U.S. Medicare Advantage. Outside the U.S., DPNCheck in Asia, which is Japan and China, posted year-on-year...
